Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
80
Views
18
CrossRef citations to date
0
Altmetric
Original Research

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection

Hongzhi Liu1 Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, People’s Republic of China;2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China
,
Hui Chen1 Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, People’s Republic of China
,
Xiaomo Wu3 Department of Biomedicine, University of Basel, Basel 4056, Switzerland;4 Dermatology Institute of Fuzhou, Dermatology Hospital of Fuzhou, Fuzhou 350025, People’s Republic of China
,
Ying Sun2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China
,
Yingchao Wang2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China
,
Yongyi Zeng1 Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, People’s Republic of China;2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China
,
Geng Chen2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China
,
Xiaolong Liu2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China
,
Xiaohua Xing2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China;5 The School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350004, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Bixing Zhao2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China
&
Jingfeng Liu1 Department of Gastrointestinal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350007, People’s Republic of China;2 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People’s Republic of China
 show all
Pages 2935-2946 | Published online: 10 Apr 2019

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Andrea Casadei-Gardini, Orsi Giulia, Caputo Francesco & Ercolani Giorgio. (2020) Developments in predictive biomarkers for hepatocellular carcinoma therapy. Expert Review of Anticancer Therapy 20:1, pages 63-74.
Read now

Articles from other publishers (17)

Jiaqi Yi, Xuehua Luo, Weijian Huang, Weijun Yang, Yan Qi, Jun He & Huijun Xie. (2024) PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma. Oncology Letters 27:3.
Crossref
Xiaohua Xing, Linsheng Cai, Jiahe Ouyang, Fei Wang, Zongman Li, Mingxin Liu, Yingchao Wang, Yang Zhou, En Hu, Changli Huang, Liming Wu, Jingfeng Liu & Xiaolong Liu. (2023) Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma. Nature Communications 14:1.
Crossref
Kexin Zhang, Lixue Sun & Yuanyuan Kang. (2023) Regulation of phosphoglycerate kinase 1 and its critical role in cancer. Cell Communication and Signaling 21:1.
Crossref
Xu Xin, Yu Jia-Yin, Huang Jun-Yang, Wang Rui, Kuang Xiong-Ri, Dang Long-Rui, Jie Liu & Zhou Jue-Yu. (2023) Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis. Computers in Biology and Medicine 159, pages 106943.
Crossref
Wenhu Liu, Qiang Wang, Jinxia Chang, Anup Bhetuwal, Nisha Bhattarai, Fan Zhang & Jiancai Tang. (2022) Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma. Clinical Proteomics 19:1.
Crossref
Yuyuan Chen, Lvjun Cen, Rong Guo, Sheng Huang & Dedian Chen. (2022) Roles and mechanisms of phosphoglycerate kinase 1 in cancer. Bulletin du Cancer 109:12, pages 1298-1307.
Crossref
Ju Yeon Kim, Jaenyeon Kim, Young-Suk Lim, Geum-Youn Gwak, Injoon Yeo, Yoseop Kim, Jihyeon Lee, Dongyoon Shin, Jeong-Hoon Lee & Youngsoo Kim. (2022) Proteome Multimarker Panel for the Early Detection of Hepatocellular Carcinoma: Multicenter Derivation, Validation, and Comparison. ACS Omega 7:34, pages 29934-29943.
Crossref
Yu He, Xixi Wang, Weiliang Lu, Dan Zhang, Lan Huang, Yang Luo, Li Xiong, Haocheng Li, Peng Zhang, Qiu Li & Shufang Liang. (2022) PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis. Cell Death & Disease 13:2.
Crossref
Francesco Greco, Federica Anastasi, Luca Fidia Pardini, Marialaura Dilillo, Eleonora Vannini, Laura Baroncelli, Matteo Caleo & Liam A. McDonnell. (2021) Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model. Molecules 26:19, pages 5992.
Crossref
Juqiang Zhang, Hao Peng, Botian Wang, Lei Luo, Yuan Cheng, Guolin He, Yujun Tang & MingXin Pan. (2021) Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell. Journal of Gastrointestinal Surgery 25:7, pages 1770-1778.
Crossref
Yu-Chan Chang, Ming-Hsien Chan, Chien-Hsiu Li, Chih-Jen Yang, Yu-Wen Tseng, Hsing-Fang Tsai, Jean Chiou & Michael Hsiao. (2021) Metabolic protein phosphoglycerate kinase 1 confers lung cancer migration by directly binding HIV Tat specific factor 1. Cell Death Discovery 7:1.
Crossref
Maria Tampaki, George Vasileios Papatheodoridis & Evangelos Cholongitas. (2021) Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 14:3, pages 699-713.
Crossref
Xiaohua Xing, Hui Yuan, Hongzhi Liu, Xionghong Tan, Bixing Zhao, Yingchao Wang, Jiahe Ouyang, Minjie Lin, Xiaolong Liu & Aimin Huang. (2021) Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma. Genomics, Proteomics & Bioinformatics 19:1, pages 94-107.
Crossref
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford & Chamindie Punyadeera. (2020) The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:2, pages 188451.
Crossref
Nia Adeniji & Renumathy Dhanasekaran. (2020) Genomic Landscape of HCC. Current Hepatology Reports 19:4, pages 448-461.
Crossref
Qi Fu & Zhenhai Yu. (2020) Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy. Life Sciences 256, pages 117863.
Crossref
Fan Zhang, Yong Jia, Xiao Zheng, Dan Shao, Yawei Zhao, Zheng Wang, Jianati Dawulieti, Wenliang Liu, Madi Sun, Wen Sun, Yue Pan, Lianzhi Cui, Yanan Wang, Kan He, Ming Zhang, Jing Li, Wen-fei Dong & Li Chen. (2019) Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence. Acta Biomaterialia 100, pages 352-364.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.